Non-Hodgkin's Lymphoma in Childhood and AdolescenceOussama Abla, Andishe Attarbaschi Springer, 09.04.2019 - 376 Seiten This text provides a state-of-the-art overview on Non-Hodgkin's lymphoma (NHL) in children and adolescents. The volume is divided into seven sections, each of which focuses on a critical component of pediatric NHL, including history and epidemiology, pathology and molecular biology, disease evaluation and response, common and rare sub-types of NHL, and current and novel treatment strategies. The text also comprehensively reviews the late effects of treatment, quality of patient life, and NHL treatment in countries with limited resources. Written by experts in the field, Non-Hodgkin's Lymphoma in Childhood and Adolescence is a valuable resource for clinicians and practitioners who treat children and adolescents with NHL. |
Inhalt
Pathology and Molecular Biology | 30 |
Evaluation | 111 |
Lymphoblastic Lymphoma | 150 |
Mature B NonHodgkins Lymphomas | 165 |
Mature T NonHodgkins Lymphomas | 248 |
Treatment | 292 |
| 367 | |
Andere Ausgaben - Alle anzeigen
Non-Hodgkin's Lymphoma in Childhood and Adolescence Oussama Abla,Andishe Attarbaschi Keine Leseprobe verfügbar - 2019 |
Häufige Begriffe und Wortgruppen
acute lymphoblastic leukemia adult ALCL ALK-positive ALK+ analysis anaplastic large cell antibody antigen associated B-NHL bone marrow bortezomib Burkhardt Burkitt lymphoma chemotherapy Childhood and Adolescence children and adolescents chromosome classification Clin Oncol clinical cyclophosphamide cytotoxic detected diagnosis diffuse large B-cell disease DLBCL Epstein-Barr virus expression extranodal follicular lymphoma gene genetic Haematol hematopoietic Hodgkin lymphoma HSCT immune immunophenotype infection inhibitors involvement kinase large B-cell lymphoma lenalidomide lesions lymphoblastic lymphoma lymphoid lymphoma in children lymphoproliferative disorder malignancies marginal zone mature B-cell methotrexate molecular mutations non-Hodgkin lymphoma NPM-ALK Oschlies outcome Pathol PCNSL Pediatr Blood Cancer pediatric pediatric patients peripheral T-cell lymphoma Perkins SL phase phoma PMBCL post-transplant primary mediastinal prognostic protein protocol PTLD rearrangements receptor regimens reported response risk rituximab stage stem cell transplantation subtype survival T-ALL T-LBL therapy tion translocation treatment trial tumor cells Zimmermann